Showing results (421-430 of 1,557) with videos related to

Sort By:
Pageof 156
Therapeutic Advances in Gastroenterology|October 4, 2019
Patterns of care in metastatic pancreatic cancer: patient selection in clinical routineWerner Scheithauer, Paul Martin Putora, Birgit Grünberger, et al.
Therapeutic Advances in Gastroenterology|April 2, 2025
Utilizing large language models for gastroenterology research: a conceptual frameworkParul Berry, Rohan Raju Dhanakshirur, Sahil Khanna
Therapeutic Advances in Gastroenterology|April 2, 2025
Transanal endoscopic local resection versus radical excision in the treatment of massive rectal gastrointestinal stromal tumors: striving for therapeutic advantagesTaixuan Wan, Jingkun Xiao, Xingwei Zhang, et al.
Therapeutic Advances in Gastroenterology|April 29, 2025
Impact of early tumor shrinkage on survival outcomes in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan in third- or later-line settingsKoshiro Fukuda, Hiroki Osumi, Keitaro Shimozaki, et al.
Therapeutic Advances in Gastroenterology|April 29, 2025
Complete closure utilizing titanium clips minimizes delayed postpolypectomy bleeding after colorectal endoscopic mucosal resection: a retrospective analysisWei-Feng Li, Bing Lai, Li Lv, et al.
Therapeutic Advances in Gastroenterology|April 29, 2025
Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational studyGabrielle D'Abbundo, Maria Nachury, Alice Wartski, et al.
Therapeutic Advances in Gastroenterology|April 29, 2025
The effect of pre-procedural anxiety level on the quality of upper GI endoscopy in non-sedated patients: "can the need for sedation be predicted?"Hulusi Can Karpuzcu, Görkem Yarbaş, Ramis Çatalbaş, et al.
Therapeutic Advances in Gastroenterology|April 28, 2025
Established nomogram based on clinicopathological characteristics, lifestyle, and comorbidities risk factors for metachronous recurrence in curative endoscopic submucosal dissectionYing Xiang, Zhenyu Wang, Yichun Ma, et al.
Therapeutic Advances in Gastroenterology|May 5, 2025
Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trialSahil Khanna, David Yoho, Daniel Van Handel, et al.
Therapeutic Advances in Gastroenterology|March 28, 2025
Switching from intravenous to subcutaneous infliximab is safe and feasible in patients with perianal Crohn's diseasePauline Wils, Mathurin Fumery, Maria Nachury, et al.
Pageof 156